Notification of a Public Teleconference of the President's Commission on Combating Drug Addiction and the Opioid Crisis (Commission), 26813 [2017-12023]

Download as PDF Federal Register / Vol. 82, No. 110 / Friday, June 9, 2017 / Notices community response to the new, quieter, sonic booms. II. Method of Collection Telephone. III. Data Title: Pilot Testing of Telephone Interviewing Approaches to Assess Community Response to New, Quieter Boom Experiences. OMB Number: 2700–XXXX. Type of review: New information collection. Affected Public: Individuals. Estimated Number of Respondents: 5,000. Estimated Time per Response: 3 minutes. Estimated Total Annual Burden Hours: 250. Estimated Total Annual Cost to Respondents: $0. IV. Request for Comments Comments are invited on: (1) Whether the proposed collection of information is necessary for the proper performance of the functions of NASA, including whether the information collected has practical utility; (2) the accuracy of NASA’s estimate of the burden (including hours and cost) of the proposed collection of information; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including automated collection techniques or the use of other forms of information technology. Comments submitted in response to this notice will be summarized and included in the request for OMB approval of this information collection. They will also become a matter of public record. Frances Teel, NASA PRA Clearance Officer. [FR Doc. 2017–12000 Filed 6–8–17; 8:45 am] BILLING CODE 7510–13–P OFFICE OF NATIONAL DRUG CONTROL POLICY mstockstill on DSK30JT082PROD with NOTICES Notification of a Public Teleconference of the President’s Commission on Combating Drug Addiction and the Opioid Crisis (Commission) Office of National Drug Control Policy (ONDCP). ACTION: Notice of teleconference. AGENCY: ONDCP announces a meeting by teleconference of the President’s Commission on Combating Drug Addiction and the Opioid Crisis. The SUMMARY: VerDate Sep<11>2014 19:25 Jun 08, 2017 Jkt 241001 purpose of the meeting is to review a draft interim report that will be posted on ONDCP’s Commission Web site listed below before the teleconference. DATES: The teleconference will be held on Monday June 26, 2017 at 4:00 p.m. (Eastern time). ADDRESSES: There will be no physical address. The public may call (866) 233– 3841 (Access Code 425352) to listen. Please call five minutes before the start time. If you are part of an organization, please try to consolidate use to as few lines as possible. FOR FURTHER INFORMATION CONTACT: General information concerning the Commission and its meetings can be found on ONDCP’s Web site at https:// www.whitehouse.gov/ondcp/presidentscommission. Any member of the public wishing to obtain information about the Commission or its meetings that is not already on ONDCP’s Web site or who wishes to submit written comments for the Commission’s consideration may contact Michael Passante, Designated Federal Officer (DFO) via email at commission@ondcp.eop.gov or telephone at (202) 395–6709. Please note that ONDCP may post such written comments publicly on our Web site, including names and contact information that are submitted. There will not be oral comments from the public on the teleconference. Requests to accommodate disabilities should also be sent to that email address, preferably at least 10 days prior to the meeting to allow time for processing. SUPPLEMENTARY INFORMATION: The Commission was established in accordance with E.O. 13784 of March 29, 2017, the Commission’s charter, and the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. App. 2, to obtain advice and recommendations for the President regarding drug issues. The Executive Order, charter, and information on the Members of the Commission are available on ONDCP’s Web site. The Commission will function solely as an advisory body and will make recommendations regarding policies and practices for combating drug addiction with particular focus on the current opioid crisis in the United States. The Commission’s final report is due October 1, 2017 unless there is an extension. Per E.O. 13784, the Commission shall: a. Identify and describe the existing Federal funding used to combat drug addiction and the opioid crisis; b. assess the availability and accessibility of drug addiction treatment services and overdose reversal PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 26813 throughout the country and identify areas that are underserved; c. identify and report on best practices for addiction prevention, including healthcare provider education and evaluation of prescription practices, collaboration between State and Federal officials, and the use and effectiveness of State prescription drug monitoring programs; d. review the literature evaluating the effectiveness of educational messages for youth and adults with respect to prescription and illicit opioids; e. identify and evaluate existing Federal programs to prevent and treat drug addiction for their scope and effectiveness, and make recommendations for improving these programs; and; f. make recommendations to the President for improving the Federal response to drug addiction and the opioid crisis. Dated: June 6, 2017. Michael Passante, Acting General Counsel, Designated Federal Officer. [FR Doc. 2017–12023 Filed 6–8–17; 8:45 am] BILLING CODE 3280–F5–P NATIONAL SCIENCE FOUNDATION Sunshine Act Meeting; National Science Board The National Science Board’s Committee on Awards and Facilities (A&F), pursuant to NSF regulations (45 CFR part 614), the National Science Foundation Act, as amended (42 U.S.C. 1862n–5), and the Government in the Sunshine Act (5 U.S.C. 552b), hereby gives notice of the scheduling of a teleconference for the transaction of National Science Board business, as follows: DATES AND TIME: Friday, June 16, 2017 from 11:00 a.m.–12:00 p.m. EDT. SUBJECT MATTER: Committee Chair’s opening remarks; discussion of Information-Action Item Sequence; the Lead Reviewer Guide; the Portfolio Level Information in Facility Portal; and Committee Chair’s closing remarks. STATUS: Open. LOCATION: This meeting will be held by teleconference at the National Science Foundation, 4201 Wilson Blvd., Arlington, VA 22230. An audio link will be available for the public. Members of the public must contact the Board Office to request the public audio link by sending an email to nationalsciencebrd@nsf.gov at least 24 hours prior to the teleconference. E:\FR\FM\09JNN1.SGM 09JNN1

Agencies

[Federal Register Volume 82, Number 110 (Friday, June 9, 2017)]
[Notices]
[Page 26813]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-12023]


=======================================================================
-----------------------------------------------------------------------

OFFICE OF NATIONAL DRUG CONTROL POLICY


Notification of a Public Teleconference of the President's 
Commission on Combating Drug Addiction and the Opioid Crisis 
(Commission)

AGENCY: Office of National Drug Control Policy (ONDCP).

ACTION: Notice of teleconference.

-----------------------------------------------------------------------

SUMMARY: ONDCP announces a meeting by teleconference of the President's 
Commission on Combating Drug Addiction and the Opioid Crisis. The 
purpose of the meeting is to review a draft interim report that will be 
posted on ONDCP's Commission Web site listed below before the 
teleconference.

DATES: The teleconference will be held on Monday June 26, 2017 at 4:00 
p.m. (Eastern time).

ADDRESSES: There will be no physical address. The public may call (866) 
233-3841 (Access Code 425352) to listen. Please call five minutes 
before the start time. If you are part of an organization, please try 
to consolidate use to as few lines as possible.

FOR FURTHER INFORMATION CONTACT: General information concerning the 
Commission and its meetings can be found on ONDCP's Web site at https://www.whitehouse.gov/ondcp/presidents-commission. Any member of the 
public wishing to obtain information about the Commission or its 
meetings that is not already on ONDCP's Web site or who wishes to 
submit written comments for the Commission's consideration may contact 
Michael Passante, Designated Federal Officer (DFO) via email at 
commission@ondcp.eop.gov or telephone at (202) 395-6709. Please note 
that ONDCP may post such written comments publicly on our Web site, 
including names and contact information that are submitted. There will 
not be oral comments from the public on the teleconference. Requests to 
accommodate disabilities should also be sent to that email address, 
preferably at least 10 days prior to the meeting to allow time for 
processing.

SUPPLEMENTARY INFORMATION: The Commission was established in accordance 
with E.O. 13784 of March 29, 2017, the Commission's charter, and the 
provisions of the Federal Advisory Committee Act (FACA), as amended, 5 
U.S.C. App. 2, to obtain advice and recommendations for the President 
regarding drug issues. The Executive Order, charter, and information on 
the Members of the Commission are available on ONDCP's Web site. The 
Commission will function solely as an advisory body and will make 
recommendations regarding policies and practices for combating drug 
addiction with particular focus on the current opioid crisis in the 
United States. The Commission's final report is due October 1, 2017 
unless there is an extension. Per E.O. 13784, the Commission shall:
    a. Identify and describe the existing Federal funding used to 
combat drug addiction and the opioid crisis;
    b. assess the availability and accessibility of drug addiction 
treatment services and overdose reversal throughout the country and 
identify areas that are underserved;
    c. identify and report on best practices for addiction prevention, 
including healthcare provider education and evaluation of prescription 
practices, collaboration between State and Federal officials, and the 
use and effectiveness of State prescription drug monitoring programs;
    d. review the literature evaluating the effectiveness of 
educational messages for youth and adults with respect to prescription 
and illicit opioids;
    e. identify and evaluate existing Federal programs to prevent and 
treat drug addiction for their scope and effectiveness, and make 
recommendations for improving these programs; and;
    f. make recommendations to the President for improving the Federal 
response to drug addiction and the opioid crisis.

    Dated: June 6, 2017.
Michael Passante,
Acting General Counsel, Designated Federal Officer.
[FR Doc. 2017-12023 Filed 6-8-17; 8:45 am]
 BILLING CODE 3280-F5-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.